Form 485BXT NEOS ETF Trust

As filed with the Securities and Exchange Commission on December 17, 2024

 

Securities Act File No. 333-253997
Investment Company Act File No. 811-23645

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

 

FORM N-1A

 

---

 

	☒ REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933
	☐ Pre-Effective Amendment No.__
	☒ Post-Effective Amendment No. 173
	AND/OR
	☒ REGISTRATION STATEMENT UNDER THE INVESTMENT COMPANY ACT OF 1940
	☒ Amendment No. 174

 

---

 

NEOS ETF TRUST

(Exact Name of Registrant as Specified in its Charter)

 

---

 

13 Riverside Ave
Westport, CT 06880
(Address of Principal Executive Offices)

 

Registrant’s Telephone Number, including Area Code: 203.298.7300

 

The Corporation Trust Company
Corporation Trust Center
1209 Orange Street
Wilmington, Delaware 19801
(Name and address of agent for service)

 

---

 

Copy to:

 

Garrett Paolella
NEOS ETF Trust
13 Riverside Ave
Westport, CT 06880

 

Bibb L. Strench, Esq.
Thompson Hine LLP
1919 M Street, N.W., Suite 700
Washington, D.C. 20036

 

---

 

It is proposed that this filing will become effective:

☐ Immediately upon filing pursuant to paragraph (b)

☒ On December 19, 2024 pursuant to paragraph (b)

☐ 60 days after filing pursuant to paragraph (a)(1)

☐ On (date) pursuant to paragraph (a)(1)

☐ 75 days after filing pursuant to paragraph (a)(2)

☐ On (date) pursuant to paragraph (a)(2) of Rule 485.

 

If appropriate, check the following box:

☒ This post-effective amendment designates a new effective date for a previously filed post-effective amendment

 

 

Parts A, B and C filed in Post-Effective Amendment No. 166 to the Registration Statement of NEOS ETF Trust on behalf of FIS Bright Portfolios Focused Equity ETF as filed with the Securities and Exchange Commission pursuant to Rule 485(a) under the Securities Act of 1933 on October 4, 2024 (Accession Number 0001999371-24-013003), are herein incorporated by reference. This filing is being made pursuant to Rule 485(b)(1)(iii) under the Securities Act of 1933 to extend the effectiveness of the Registration Statement until December 19, 2024.

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Act of 1933 and the Investment Company Act of 1940, the Registrant certifies that it meets all of the requirement for effectiveness of this Registration Statement under rule 485(b) under the Securities Act of 1933 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, duly authorized, in the city of Westport, and State of Connecticut, on the 17^th day of December 2024.

 

	NEOS ETF Trust
	By:	/s/ Garrett Paolella
	Name:	Garrett Paolella
	Title:	President, Principal Executive Officer, and Trustee

Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed below by the following person in the capacities and on the date indicated.

 

Signature		Title		Date
/s/ Garrett Paolella		President, Principal Executive Officer, Trustee and Chairman		December 17, 2024
Garrett Paolella
/s/ Troy Cates		Trustee and Vice Chairman		December 17, 2024
Troy Cates
*		Trustee		December 17, 2024
Sharon Cheever
*		Trustee		December 17, 2024
Richard Keary
*		Trustee		December 17, 2024
John Jacobs
*		Trustee		December 17, 2024
Robert Sherry
/s/ Josh Hunter		Treasurer and Principal Financial Officer		December 17, 2024
Josh Hunter

*By:	/s/ Garrett Paolella
	Garrett Paolella

 

* Attorney-in-Fact – Signed pursuant to a Power of Attorney dated March 26, 2024 for Ms. Sharon Cheever, and Mr. Richard Keary; a Power of Attorney dated March 27, 2024 for Mr. Robert Sherry; and a Power of Attorney dated March 28, 2024 for Mr. John Jacobs; and filed with Registrant’s registration statement on Form N-1A dated April 18, 2024 and herein incorporated by reference.

 

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• LifeCare Development Announces The Blake at Chattanooga
• Wolfson Group Acquires Portfolio of Wellness Brands to Accelerate U.S. Expansion
• Carmed Pharmaceuticals Highlights Science Behind Its Botanical Wellness Formulations Ahead of Walmart.com Expansion